Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for BNKK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -2.226M
March 31, 2026 -1.942M
December 31, 2025 -7.140M
September 30, 2025 -12.78M
June 30, 2025 -0.7289M
March 31, 2025 -4.628M
December 31, 2024 -1.547M
September 30, 2024 -5.44M
June 30, 2024 -5.713M
March 31, 2024 -6.388M
December 31, 2023 -5.533M
September 30, 2023 -2.210M
June 30, 2023 -1.202M
March 31, 2023 -1.169M
December 31, 2022 -1.389M
Date Value
September 30, 2022 -1.297M
June 30, 2022 -0.9967M
March 31, 2022 -2.713M
December 31, 2021 -2.518M
September 30, 2021 -1.813M
June 30, 2021 -1.983M
March 31, 2021 -1.254M
December 31, 2020 -1.418M
September 30, 2020 -0.4658M
June 30, 2020 -0.3917M
March 31, 2020 -0.4576M
December 31, 2019 -0.3134M
September 30, 2019 -0.1935M
June 30, 2019 -0.0784M
March 31, 2019 -0.1075M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. -0.027M
Skinhealth Systems, Inc. 2.671M
Evercore Holdings, Inc. -0.0219M
DND Technologies, Inc. --
CCA Industries, Inc. -0.3804M